Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach

Varduhi Petrosyan(Baylor College of Medicine), Michael T. Lewis(Baylor College of Medicine), Suhas Vasaikar(Baylor College of Medicine), Gerburg M. Wulf(Beth Israel Deaconess Medical Center), Antrix Jain(Baylor College of Medicine), Christina Sallas(Baylor College of Medicine), Heidi Dowst(Baylor College of Medicine), C. Kent Osborne(Baylor College of Medicine), Shunqiang Li(Washington University in St. Louis), Alaina Lewis(Baylor College of Medicine), Olmo Sonzogni(Beth Israel Deaconess Medical Center), Predrag Obradović(University of Belgrade), Chen Huang(Baylor College of Medicine), Lacey E. Dobrolecki(Baylor College of Medicine), Maryam Nemati Shafaee(Baylor College of Medicine), Alexander B. Saltzman, Lillian R Thistlethwaite(Baylor College of Medicine), Jonathan T. Lei(Baylor College of Medicine), Matthew J. Ellis(Guardant (United States)), Elisabetta Marangoni(Institut Curie), Mothaffar F. Rimawi(Baylor College of Medicine), Susan G. Hilsenbeck(Baylor College of Medicine), Bryan E. Welm(University of Minnesota), Anne C. Pavlick(Baylor College of Medicine), Ramakrishnan Rajaram Srinivasan(Baylor College of Medicine), Aleksandar Milosavljevic(Baylor College of Medicine), Bing Zhang(Baylor Genetics), Alana L. Welm(Huntsman Cancer Institute), Vladimir Kovačević(University of Belgrade), Anna Malovannaya(Baylor College of Medicine)
iScience
December 12, 2022
Cited by 35


Related Papers